Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Risk of Fracture Prevalence and Glycemic Control in Korean Older and Middle-aged Patients with Diabetes: A Retrospective Analysis of a Cohort Derived from the Korean National Health Insurance Sharing Service Database, 2009-2013

노인과 중년 당뇨병 환자의 골절의 발생 빈도 위험과 혈당조절의 관계

  • Sin, Hye Yeon (College of Pharmacy, Duksung Women's University)
  • 신혜연 (덕성여자대학교 약학대학)
  • Received : 2018.06.19
  • Accepted : 2018.09.19
  • Published : 2018.09.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Bone fractures are high in elderly patients with type 2 diabetes mellitus (T2DM). Hyperglycemia and chronic kidney disease may increase the risk of fracture prevalence via altered bone metabolism, but whether glycemic control and kidney function are associated with the risk of fracture prevalence remains unclear. This study evaluated the relationship between glycemic control and baseline estimated glomerular filtration rate (eGFR) and risk of fracture prevalence in older and middle-aged patients with T2DM. Methods: Patients who underwent a general medical check-up between 2009 and 2013 were selected from the Korean National Health Insurance Sharing Service records. Chi-square test and multiple logistic regression analysis were used to assess the relationship between glycemic control and eGFR and risk of fracture prevalence. Results: Cumulative fracture prevalence were higher in patients with T2DM, irrespective of whether they had tight or less stringent glycemic control (fasting blood glucose [FBG] ${\geq}110mg/dL$). After adjustment for baseline age and FBG, tight and less stringent glycemic control was significantly associated with increased adjusted risk of fracture prevalence in middle-aged patients with T2DM (OR=1.13, 95% CI, 1.05-1.21, p=0.0005 vs OR=1.13, 95% CI, 1.06-1.20, p=0.0001), but not in older patients. Baseline eGFR was not significantly related to fracture prevalence in either older or middle-aged patients. Conclusion: Less stringent glycemic control significantly increased the adjusted risk of fracture prevalence in middle-aged patients with T2DM. Further studies are needed to confirm the effect of tight glycemic control on fracture prevalence.

Keywords

References

  1. Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25:1749-54. https://doi.org/10.2337/diacare.25.10.1749
  2. Cortes-Sancho R, Perez-Castrillon JL, Martin-Escudero JC, et al. Type 2 diabetes mellitus as a risk factor for hip fracture. J Am Geriatr Soc 2004; 52: 1778-9. https://doi.org/10.1111/j.1532-5415.2004.52479_2.x
  3. Lee RH, Pieper CF, Colon-Emeric C. Functional impairments mediate association between clinical fracture risk and Type 2 diabetes mellitus in older women. J Am Geriatr Soc 2015; 63:1546-51. https://doi.org/10.1111/jgs.13556
  4. Wallander M, Axelsson K, Nilsson AG, et al. Type 2 Diabetes and risk of hip fractures and on-skeletal fall injuries in the old age: A study from the fractures and fall injuries in the old age cohort (FRAILCO). J Bone Miner Res 2016;31:1-12. https://doi.org/10.1002/jbmr.2616
  5. Conway BN. Glycemic control and fracture risk in old age patients with diabetes. Diabetes Res Clin Pract 2016; 115: 47-53. https://doi.org/10.1016/j.diabres.2016.03.009
  6. Sanches C, Vianna AGD, Barreto FC. The impact of type 2 diabetes on bone metabolism. Diabetol Metab Syndr 2017; 9: 1-7. https://doi.org/10.1186/s13098-016-0201-1
  7. Liao CC, Lin CS, Shih CC et al. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 2014; 37: 2246- 52. https://doi.org/10.2337/dc13-2957
  8. Starup-Linde J, Gregersen S, Frost M et al. Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes. Bone 2017:95; 136-42. https://doi.org/10.1016/j.bone.2016.11.026
  9. Janghorbani M, VanDam RM, Willett WC, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007; 166: 495-505. https://doi.org/10.1093/aje/kwm106
  10. Mishima T, Motoyama K, Imanishi Y, et al. Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/$1.73{\;}m^2$. Osteoporos Int 2015; 26: 229-36. https://doi.org/10.1007/s00198-014-2843-x
  11. Vestergaard P. Diabetes and bone fracture: risk factors for old and middle age. Diabetologia 2014; 57: 2007-8. https://doi.org/10.1007/s00125-014-3338-1
  12. Moayeri A, Mohamadpour M, Mousavi SF, et al. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag 2017;13: 55-68.
  13. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology of the comprehensive type2 diabetes management algorithm-2018 Executive Summary. Endocr Pract 2018; 24:91-120. https://doi.org/10.4158/CS-2017-0153
  14. Hirakawa Y, Arima H, Zoungas S, et al. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial. Diabetes Care 2014; 37: 2359-65. https://doi.org/10.2337/dc14-0199
  15. Miller ME, Williamson JD, Gerstein HC, et al. ACCORD Investigators. Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial. Diabetes Care 2014; 37: 634-43. https://doi.org/10.2337/dc13-1545
  16. Cefalu WT, Abate N, Aroda VR, et al. American diabetes association Standards of medical care in diabetes-2017. Diabetes Care 2017; 40(Suppl. 1):S25-S32. https://doi.org/10.2337/dc17-S006
  17. Chiang JI, Li TC, Li CI, et al. Visit-to-visit variation of fasting blood glucose is a predictor of hip fracture in older persons with type 2diabetes: the Taiwan Diabetes Study. Osteoporos Int 2016:27:3587-97. https://doi.org/10.1007/s00198-016-3689-1
  18. Dooley AC, Weiss NS, Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis 2008; 51:38-44. https://doi.org/10.1053/j.ajkd.2007.08.019
  19. Melton LJ, Leibson CL, Achenbach SJ, et al. Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study. J Bone Miner Res 2008; 23:1334-41. https://doi.org/10.1359/jbmr.080323
  20. Puar TH, Khoo JJ, Cho LW, et al. Association between glycemic control and hip fracture. J Am Geriatr Soc 2012; 60:1493-7. https://doi.org/10.1111/j.1532-5415.2012.04052.x
  21. Farr JN, Melton LJ 3rd, Achenbach SJ, et al. Fracture prevalence and Characteristics in Young Adults Aged 18 to 49 Years: A Population-Based Study. J Bone Miner Res 2017; 32: 2347-54. https://doi.org/10.1002/jbmr.3228
  22. Bacchetta J, Boutroy S, Vilayphiou N, et al.Norio Kurumatani Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res 2010; 25: 849-57.
  23. Isakova T, Craven TE, Scialla JJ, et al. Change in Estimated Glomerular Filtration Rate and Fracture Risk in the Action to Control Cardiovascular Risk in Diabetes Trial. Bone 2015; 78: 23-7. https://doi.org/10.1016/j.bone.2015.04.037
  24. McNair P, Madsbad S, Christensen MS, et al. Bone mineral loss in insulin treated diabetes mellitus: studies on pathogenesis. Act an Endocrinol (Copenh) 1979; 90: 463-72. https://doi.org/10.1530/acta.0.0900463
  25. Malluche HH, Porter DS, Pienkowski D. Evaluating bone quality in patients with chronic kidney disease. Nat Rev Nephrol 2013; 9: 671-80. https://doi.org/10.1038/nrneph.2013.198
  26. Schwartz AV, Karen L, Margolis KL, et al. Intensive Glycemic Control Is Not Associated with Fractures or Falls in the ACCORD Randomized Trial. Diabetes Care 2012; 35:1525-31. https://doi.org/10.2337/dc11-2184
  27. Savvidis C, Tournis S, Dede AD. Obesity and bone metabolism. Hormones (Athens) 2018; 17: 205-17. https://doi.org/10.1007/s42000-018-0018-4
  28. Losada-Grande E, Hawley S, Soldevila B, et al. Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis. Scientific Reports 2017; 19: 1-9.
  29. Schwartz AV, Karen L, Hillier TA, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25:1749-54. https://doi.org/10.2337/diacare.25.10.1749
  30. Shanbhogue VV, Hansen S, Frost M, et al. Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease. Eur J Endocrinol 2016; 174: 115-24. https://doi.org/10.1530/EJE-15-0860
  31. Napoli N, Schwartz AV, Anne L, et al. Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study. J Bone Miner Res; 33: 63-9. https://doi.org/10.1002/jbmr.3287
  32. Robert G, Josse MB, Sumit R, et al. Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. Diabetes Obes Metab 2017; 19: 78-86. https://doi.org/10.1111/dom.12786
  33. Ivers RQ, Cumming RG, Mitchell P, et al. Diabetes and Risk of Fracture. The Blue Mountains Eye Study. Diabetes Care 2001; 24: 1198-203. https://doi.org/10.2337/diacare.24.7.1198
  34. Beam HA, Parsons JR, Linet SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 2002; 20: 1210-16. https://doi.org/10.1016/S0736-0266(02)00066-9
  35. Shu A, Yin MT, Stein E, et al. Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 2012; 23: 635-41. https://doi.org/10.1007/s00198-011-1595-0
  36. McCarthy AD, Uemura T, Etcheverry SB, et al. Advanced glycation end products interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol 2004; 36: 840-8. https://doi.org/10.1016/j.biocel.2003.09.006
  37. Zanatta LC, Boguszewski CL, Borba VZ, et al. Osteocalcin, energy and glucose metabolism. Arq Bras Endocrinol Metab 2014; 58: 444-51. https://doi.org/10.1590/0004-2730000003333
  38. Lemming DJ, Alexandersen P, Karsdal MA, et al. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 2006; 62:781-92. https://doi.org/10.1007/s00228-006-0174-3
  39. Losada-Grande E, Hawley S, Soldevila B, et al. Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis. Sci Rep 2017; 19: 1-9.
  40. Hygum K, Starup-Linde J, Harslof T, et al. Mechanisms in endocrinology: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol 2017; 176: R137-R157. https://doi.org/10.1530/EJE-16-0652
  41. Park BJ, Sung J, Park K, et al. Studying on diagnosis accuracy for health insurance claims data in Korea. Seoul: Seoul National University, 2003, p. 17-29.
  42. Kim JA, Yoon SK, Kim LY, et al. Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data. Korean Med Sci 2017; 32: 718-28. https://doi.org/10.3346/jkms.2017.32.5.718
  43. Kimm H, Yun JE, Lee SH, et al. Validity of the diagnosis of acute myocardial infarction in korean national medical health insurance claims data: the korean heart study (1). Korean Circ J 2012; 42: 10-5. https://doi.org/10.4070/kcj.2012.42.1.10